Hebrew University-Hadassah Braun School of Public Health and Community Medicine, Jerusalem, Israel.
Division of Enforcement and Inspection, Israel Ministry of Health, Jerusalem, Israel.
Subst Use Misuse. 2021;56(5):627-638. doi: 10.1080/10826084.2021.1887246. Epub 2021 Mar 4.
Self-substitution is the conscious switch from one drug to another for reasons such as price, availability, desired effect, or perceived benefit of the substitute drug. This study aimed to describe drug use patterns and motivations associated with substitution. We examined correlates of lifetime substitution among individuals with substance use disorder. A cross-sectional study of 771 treatment-enrolled individuals. We used self-report for determining the lifetime prevalence, correlates, and motivations for substitution. Of the 771 respondents, 570 (73.9%) reported ever substituting their preferred substance. The main incentives for substitution were availability (23.7%) and curiosity (20.2%). Among heroin or cannabis preferers, improved effects or less adverse effects of the substitute drug, self-medication, and managing withdrawal symptoms were significant substitution incentives. Increased odds for substitution were observed for past 12months use of cannabis (OR = 1.51, CI = 1.06-4.52), prescription opioids (OR = 2.86, CI = 1.81-4.52), novel psychoactive substances (OR = 2.68, CI = 1.64-4.36), and repeated admission (OR = 1.50, CI = 1.05-2.14). Older age at onset-of-use was negatively associated with substitution (OR = 0.95, CI = 0.93-0.98). Self-substitution of one substance for another is a highly prevalent behavior among treatment-enrolled patients with substance use disorder. Clinicians caring for substance use disorder patients should be aware of substitution patterns involving the use of highly potent substances, which constitutes a risk to patients. Results underscore the benefit of substitution patterns analyses, as they reveal important information on the characteristics of persons who use drugs and their motivations.
自我替代是指出于价格、可得性、期望效果或替代药物的益处等原因,有意识地从一种药物切换到另一种药物。本研究旨在描述与替代相关的药物使用模式和动机。我们检查了物质使用障碍个体一生中替代的相关性。这是一项针对 771 名接受治疗的个体的横断面研究。我们使用自我报告来确定一生中替代的流行率、相关性和动机。在 771 名受访者中,570 名(73.9%)报告曾经替代过他们首选的物质。替代的主要动机是可得性(23.7%)和好奇心(20.2%)。对于海洛因或大麻偏好者,替代药物的效果改善或不良反应减少、自我治疗和管理戒断症状是重要的替代动机。过去 12 个月使用大麻(OR = 1.51,CI = 1.06-4.52)、处方阿片类药物(OR = 2.86,CI = 1.81-4.52)、新型精神活性物质(OR = 2.68,CI = 1.64-4.36)和重复入院(OR = 1.50,CI = 1.05-2.14)与替代的几率增加有关。发病年龄越大,替代的可能性越小(OR = 0.95,CI = 0.93-0.98)。
自我替代一种物质替代另一种物质是接受物质使用障碍治疗的患者中一种高度普遍的行为。照顾物质使用障碍患者的临床医生应该意识到涉及使用高活性物质的替代模式,这对患者构成风险。结果强调了替代模式分析的益处,因为它们揭示了有关使用药物的人的特征和动机的重要信息。